Klotho-VS heterozygosity in patients above 60 years of age was associated with a reduced risk of developing AD and progression from mild cognitive impairment (MCI)—defined as a stage between regular aging and AD [37]—to fully symptomatic AD. This evidence concerns the gene KL and Alzheimer disease.